The global Drugs for Treating Mental Disorders market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Drugs for Treating Mental Disorders market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Drugs for Treating Mental Disorders market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Drugs for Treating Mental Disorders market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
This report aims to provide a comprehensive presentation of the global market for Drugs for Treating Mental Disorders, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Treating Mental Disorders.
This report contains market size and forecasts of Drugs for Treating Mental Disorders in global, including the following market information:
- Global Drugs for Treating Mental Disorders Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Tablets Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Drugs for Treating Mental Disorders include Johnson and Johnson, Pfizer, Eli Lilly, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb, Teva Pharmaceutical, Dr. Reddy's Laboratories and Apotex Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Drugs for Treating Mental Disorders companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drugs for Treating Mental Disorders Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Drugs for Treating Mental Disorders Market Segment Percentages, by Type, 2022 (%)
- Tablets
- Capsule
- Injection
- Solution
- Other
Global Drugs for Treating Mental Disorders Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Drugs for Treating Mental Disorders Market Segment Percentages, by Application, 2022 (%)
- Antipsychotics
- Antidepressants
- Antianxiety (Anxiolyitcs)
- Anti-Seizure Medications
- Stimulants
- Cognitive Disorders And Dementia
- Sleep Disorder Treatments
- Substance Abuse Treatments
- Hypnosis And Tranquilizers
- Other
Global Drugs for Treating Mental Disorders Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Drugs for Treating Mental Disorders Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Drugs for Treating Mental Disorders revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Drugs for Treating Mental Disorders revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Johnson and Johnson
- Pfizer
- Eli Lilly
- GlaxoSmithKline
- AstraZeneca
- Bristol-Myers Squibb
- Teva Pharmaceutical
- Dr. Reddy's Laboratories
- Apotex Inc.
- Mylan Pharmaceuticals
- Par Pharmaceutical
- Aurobindo Pharma
- Torrent Pharmaceuticals
- Jubilant Lifesciences
- Sun Pharmaceutical
- Sandoz (Novartis)
- Hansoh Pharmaceutical
- WATSON Pharmaceuticals
- Zhejiang Langhua Pharmaceuticals
- Forest Laboratories
- H.Lundbeck A/S
- Amneal Pharmaceuticals
- Hetero Drugs
- Macleods Pharmaceuticals
- Silarx Pharmacueticals
- Hikma Pharmaceuticals
- Lupin Limited
- Prinston Pharmaceutical
- STI Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Drugs for Treating Mental Disorders, market overview.
Chapter 2: Global Drugs for Treating Mental Disorders market size in revenue.
Chapter 3: Detailed analysis of Drugs for Treating Mental Disorders company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Drugs for Treating Mental Disorders in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Drugs for Treating Mental Disorders Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drugs for Treating Mental Disorders Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drugs for Treating Mental Disorders Overall Market Size
2.1 Global Drugs for Treating Mental Disorders Market Size: 2022 VS 2030
2.2 Global Drugs for Treating Mental Disorders Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Drugs for Treating Mental Disorders Players in Global Market
3.2 Top Global Drugs for Treating Mental Disorders Companies Ranked by Revenue
3.3 Global Drugs for Treating Mental Disorders Revenue by Companies
3.4 Top 3 and Top 5 Drugs for Treating Mental Disorders Companies in Global Market, by Revenue in 2022
3.5 Global Companies Drugs for Treating Mental Disorders Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drugs for Treating Mental Disorders Players in Global Market
3.6.1 List of Global Tier 1 Drugs for Treating Mental Disorders Companies
3.6.2 List of Global Tier 2 and Tier 3 Drugs for Treating Mental Disorders Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Drugs for Treating Mental Disorders Market Size Markets, 2022 & 2030
4.1.2 Tablets
4.1.3 Capsule
4.1.4 Injection
4.1.5 Solution
4.1.6 Other
4.2 By Type - Global Drugs for Treating Mental Disorders Revenue & Forecasts
4.2.1 By Type - Global Drugs for Treating Mental Disorders Revenue, 2018-2023
4.2.2 By Type - Global Drugs for Treating Mental Disorders Revenue, 2024-2030
4.2.3 By Type - Global Drugs for Treating Mental Disorders Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Drugs for Treating Mental Disorders Market Size, 2022 & 2030
5.1.2 Antipsychotics
5.1.3 Antidepressants
5.1.4 Antianxiety (Anxiolyitcs)
5.1.5 Anti-Seizure Medications
5.1.6 Stimulants
5.1.7 Cognitive Disorders And Dementia
5.1.8 Sleep Disorder Treatments
5.1.9 Substance Abuse Treatments
5.1.10 Hypnosis And Tranquilizers
5.1.11 Other
5.2 By Application - Global Drugs for Treating Mental Disorders Revenue & Forecasts
5.2.1 By Application - Global Drugs for Treating Mental Disorders Revenue, 2018-2023
5.2.2 By Application - Global Drugs for Treating Mental Disorders Revenue, 2024-2030
5.2.3 By Application - Global Drugs for Treating Mental Disorders Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Drugs for Treating Mental Disorders Market Size, 2022 & 2030
6.2 By Region - Global Drugs for Treating Mental Disorders Revenue & Forecasts
6.2.1 By Region - Global Drugs for Treating Mental Disorders Revenue, 2018-2023
6.2.2 By Region - Global Drugs for Treating Mental Disorders Revenue, 2024-2030
6.2.3 By Region - Global Drugs for Treating Mental Disorders Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Drugs for Treating Mental Disorders Revenue, 2018-2030
6.3.2 US Drugs for Treating Mental Disorders Market Size, 2018-2030
6.3.3 Canada Drugs for Treating Mental Disorders Market Size, 2018-2030
6.3.4 Mexico Drugs for Treating Mental Disorders Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Drugs for Treating Mental Disorders Revenue, 2018-2030
6.4.2 Germany Drugs for Treating Mental Disorders Market Size, 2018-2030
6.4.3 France Drugs for Treating Mental Disorders Market Size, 2018-2030
6.4.4 U.K. Drugs for Treating Mental Disorders Market Size, 2018-2030
6.4.5 Italy Drugs for Treating Mental Disorders Market Size, 2018-2030
6.4.6 Russia Drugs for Treating Mental Disorders Market Size, 2018-2030
6.4.7 Nordic Countries Drugs for Treating Mental Disorders Market Size, 2018-2030
6.4.8 Benelux Drugs for Treating Mental Disorders Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Drugs for Treating Mental Disorders Revenue, 2018-2030
6.5.2 China Drugs for Treating Mental Disorders Market Size, 2018-2030
6.5.3 Japan Drugs for Treating Mental Disorders Market Size, 2018-2030
6.5.4 South Korea Drugs for Treating Mental Disorders Market Size, 2018-2030
6.5.5 Southeast Asia Drugs for Treating Mental Disorders Market Size, 2018-2030
6.5.6 India Drugs for Treating Mental Disorders Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Drugs for Treating Mental Disorders Revenue, 2018-2030
6.6.2 Brazil Drugs for Treating Mental Disorders Market Size, 2018-2030
6.6.3 Argentina Drugs for Treating Mental Disorders Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Drugs for Treating Mental Disorders Revenue, 2018-2030
6.7.2 Turkey Drugs for Treating Mental Disorders Market Size, 2018-2030
6.7.3 Israel Drugs for Treating Mental Disorders Market Size, 2018-2030
6.7.4 Saudi Arabia Drugs for Treating Mental Disorders Market Size, 2018-2030
6.7.5 UAE Drugs for Treating Mental Disorders Market Size, 2018-2030
7 Drugs for Treating Mental Disorders Companies Profiles
7.1 Johnson and Johnson
7.1.1 Johnson and Johnson Company Summary
7.1.2 Johnson and Johnson Business Overview
7.1.3 Johnson and Johnson Drugs for Treating Mental Disorders Major Product Offerings
7.1.4 Johnson and Johnson Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.1.5 Johnson and Johnson Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Drugs for Treating Mental Disorders Major Product Offerings
7.2.4 Pfizer Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Eli Lilly
7.3.1 Eli Lilly Company Summary
7.3.2 Eli Lilly Business Overview
7.3.3 Eli Lilly Drugs for Treating Mental Disorders Major Product Offerings
7.3.4 Eli Lilly Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.3.5 Eli Lilly Key News & Latest Developments
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Company Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Drugs for Treating Mental Disorders Major Product Offerings
7.4.4 GlaxoSmithKline Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.4.5 GlaxoSmithKline Key News & Latest Developments
7.5 AstraZeneca
7.5.1 AstraZeneca Company Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Drugs for Treating Mental Disorders Major Product Offerings
7.5.4 AstraZeneca Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.5.5 AstraZeneca Key News & Latest Developments
7.6 Bristol-Myers Squibb
7.6.1 Bristol-Myers Squibb Company Summary
7.6.2 Bristol-Myers Squibb Business Overview
7.6.3 Bristol-Myers Squibb Drugs for Treating Mental Disorders Major Product Offerings
7.6.4 Bristol-Myers Squibb Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.6.5 Bristol-Myers Squibb Key News & Latest Developments
7.7 Teva Pharmaceutical
7.7.1 Teva Pharmaceutical Company Summary
7.7.2 Teva Pharmaceutical Business Overview
7.7.3 Teva Pharmaceutical Drugs for Treating Mental Disorders Major Product Offerings
7.7.4 Teva Pharmaceutical Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.7.5 Teva Pharmaceutical Key News & Latest Developments
7.8 Dr. Reddy's Laboratories
7.8.1 Dr. Reddy's Laboratories Company Summary
7.8.2 Dr. Reddy's Laboratories Business Overview
7.8.3 Dr. Reddy's Laboratories Drugs for Treating Mental Disorders Major Product Offerings
7.8.4 Dr. Reddy's Laboratories Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.8.5 Dr. Reddy's Laboratories Key News & Latest Developments
7.9 Apotex Inc.
7.9.1 Apotex Inc. Company Summary
7.9.2 Apotex Inc. Business Overview
7.9.3 Apotex Inc. Drugs for Treating Mental Disorders Major Product Offerings
7.9.4 Apotex Inc. Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.9.5 Apotex Inc. Key News & Latest Developments
7.10 Mylan Pharmaceuticals
7.10.1 Mylan Pharmaceuticals Company Summary
7.10.2 Mylan Pharmaceuticals Business Overview
7.10.3 Mylan Pharmaceuticals Drugs for Treating Mental Disorders Major Product Offerings
7.10.4 Mylan Pharmaceuticals Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.10.5 Mylan Pharmaceuticals Key News & Latest Developments
7.11 Par Pharmaceutical
7.11.1 Par Pharmaceutical Company Summary
7.11.2 Par Pharmaceutical Business Overview
7.11.3 Par Pharmaceutical Drugs for Treating Mental Disorders Major Product Offerings
7.11.4 Par Pharmaceutical Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.11.5 Par Pharmaceutical Key News & Latest Developments
7.12 Aurobindo Pharma
7.12.1 Aurobindo Pharma Company Summary
7.12.2 Aurobindo Pharma Business Overview
7.12.3 Aurobindo Pharma Drugs for Treating Mental Disorders Major Product Offerings
7.12.4 Aurobindo Pharma Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.12.5 Aurobindo Pharma Key News & Latest Developments
7.13 Torrent Pharmaceuticals
7.13.1 Torrent Pharmaceuticals Company Summary
7.13.2 Torrent Pharmaceuticals Business Overview
7.13.3 Torrent Pharmaceuticals Drugs for Treating Mental Disorders Major Product Offerings
7.13.4 Torrent Pharmaceuticals Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.13.5 Torrent Pharmaceuticals Key News & Latest Developments
7.14 Jubilant Lifesciences
7.14.1 Jubilant Lifesciences Company Summary
7.14.2 Jubilant Lifesciences Business Overview
7.14.3 Jubilant Lifesciences Drugs for Treating Mental Disorders Major Product Offerings
7.14.4 Jubilant Lifesciences Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.14.5 Jubilant Lifesciences Key News & Latest Developments
7.15 Sun Pharmaceutical
7.15.1 Sun Pharmaceutical Company Summary
7.15.2 Sun Pharmaceutical Business Overview
7.15.3 Sun Pharmaceutical Drugs for Treating Mental Disorders Major Product Offerings
7.15.4 Sun Pharmaceutical Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.15.5 Sun Pharmaceutical Key News & Latest Developments
7.16 Sandoz (Novartis)
7.16.1 Sandoz (Novartis) Company Summary
7.16.2 Sandoz (Novartis) Business Overview
7.16.3 Sandoz (Novartis) Drugs for Treating Mental Disorders Major Product Offerings
7.16.4 Sandoz (Novartis) Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.16.5 Sandoz (Novartis) Key News & Latest Developments
7.17 Hansoh Pharmaceutical
7.17.1 Hansoh Pharmaceutical Company Summary
7.17.2 Hansoh Pharmaceutical Business Overview
7.17.3 Hansoh Pharmaceutical Drugs for Treating Mental Disorders Major Product Offerings
7.17.4 Hansoh Pharmaceutical Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.17.5 Hansoh Pharmaceutical Key News & Latest Developments
7.18 WATSON Pharmaceuticals
7.18.1 WATSON Pharmaceuticals Company Summary
7.18.2 WATSON Pharmaceuticals Business Overview
7.18.3 WATSON Pharmaceuticals Drugs for Treating Mental Disorders Major Product Offerings
7.18.4 WATSON Pharmaceuticals Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.18.5 WATSON Pharmaceuticals Key News & Latest Developments
7.19 Zhejiang Langhua Pharmaceuticals
7.19.1 Zhejiang Langhua Pharmaceuticals Company Summary
7.19.2 Zhejiang Langhua Pharmaceuticals Business Overview
7.19.3 Zhejiang Langhua Pharmaceuticals Drugs for Treating Mental Disorders Major Product Offerings
7.19.4 Zhejiang Langhua Pharmaceuticals Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.19.5 Zhejiang Langhua Pharmaceuticals Key News & Latest Developments
7.20 Forest Laboratories
7.20.1 Forest Laboratories Company Summary
7.20.2 Forest Laboratories Business Overview
7.20.3 Forest Laboratories Drugs for Treating Mental Disorders Major Product Offerings
7.20.4 Forest Laboratories Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.20.5 Forest Laboratories Key News & Latest Developments
7.21 H.Lundbeck A/S
7.21.1 H.Lundbeck A/S Company Summary
7.21.2 H.Lundbeck A/S Business Overview
7.21.3 H.Lundbeck A/S Drugs for Treating Mental Disorders Major Product Offerings
7.21.4 H.Lundbeck A/S Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.21.5 H.Lundbeck A/S Key News & Latest Developments
7.22 Amneal Pharmaceuticals
7.22.1 Amneal Pharmaceuticals Company Summary
7.22.2 Amneal Pharmaceuticals Business Overview
7.22.3 Amneal Pharmaceuticals Drugs for Treating Mental Disorders Major Product Offerings
7.22.4 Amneal Pharmaceuticals Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.22.5 Amneal Pharmaceuticals Key News & Latest Developments
7.23 Hetero Drugs
7.23.1 Hetero Drugs Company Summary
7.23.2 Hetero Drugs Business Overview
7.23.3 Hetero Drugs Drugs for Treating Mental Disorders Major Product Offerings
7.23.4 Hetero Drugs Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.23.5 Hetero Drugs Key News & Latest Developments
7.24 Macleods Pharmaceuticals
7.24.1 Macleods Pharmaceuticals Company Summary
7.24.2 Macleods Pharmaceuticals Business Overview
7.24.3 Macleods Pharmaceuticals Drugs for Treating Mental Disorders Major Product Offerings
7.24.4 Macleods Pharmaceuticals Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.24.5 Macleods Pharmaceuticals Key News & Latest Developments
7.25 Silarx Pharmacueticals
7.25.1 Silarx Pharmacueticals Company Summary
7.25.2 Silarx Pharmacueticals Business Overview
7.25.3 Silarx Pharmacueticals Drugs for Treating Mental Disorders Major Product Offerings
7.25.4 Silarx Pharmacueticals Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.25.5 Silarx Pharmacueticals Key News & Latest Developments
7.26 Hikma Pharmaceuticals
7.26.1 Hikma Pharmaceuticals Company Summary
7.26.2 Hikma Pharmaceuticals Business Overview
7.26.3 Hikma Pharmaceuticals Drugs for Treating Mental Disorders Major Product Offerings
7.26.4 Hikma Pharmaceuticals Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.26.5 Hikma Pharmaceuticals Key News & Latest Developments
7.27 Lupin Limited
7.27.1 Lupin Limited Company Summary
7.27.2 Lupin Limited Business Overview
7.27.3 Lupin Limited Drugs for Treating Mental Disorders Major Product Offerings
7.27.4 Lupin Limited Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.27.5 Lupin Limited Key News & Latest Developments
7.28 Prinston Pharmaceutical
7.28.1 Prinston Pharmaceutical Company Summary
7.28.2 Prinston Pharmaceutical Business Overview
7.28.3 Prinston Pharmaceutical Drugs for Treating Mental Disorders Major Product Offerings
7.28.4 Prinston Pharmaceutical Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.28.5 Prinston Pharmaceutical Key News & Latest Developments
7.29 STI Pharma
7.29.1 STI Pharma Company Summary
7.29.2 STI Pharma Business Overview
7.29.3 STI Pharma Drugs for Treating Mental Disorders Major Product Offerings
7.29.4 STI Pharma Drugs for Treating Mental Disorders Revenue in Global Market (2018-2023)
7.29.5 STI Pharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Drugs for Treating Mental Disorders Market Opportunities & Trends in Global Market
Table 2. Drugs for Treating Mental Disorders Market Drivers in Global Market
Table 3. Drugs for Treating Mental Disorders Market Restraints in Global Market
Table 4. Key Players of Drugs for Treating Mental Disorders in Global Market
Table 5. Top Drugs for Treating Mental Disorders Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Drugs for Treating Mental Disorders Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Drugs for Treating Mental Disorders Revenue Share by Companies, 2018-2023
Table 8. Global Companies Drugs for Treating Mental Disorders Product Type
Table 9. List of Global Tier 1 Drugs for Treating Mental Disorders Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drugs for Treating Mental Disorders Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Drugs for Treating Mental Disorders Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Drugs for Treating Mental Disorders Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Drugs for Treating Mental Disorders Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Drugs for Treating Mental Disorders Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Drugs for Treating Mental Disorders Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Drugs for Treating Mental Disorders Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2024-2030
Table 30. Johnson and Johnson Company Summary
Table 31. Johnson and Johnson Drugs for Treating Mental Disorders Product Offerings
Table 32. Johnson and Johnson Drugs for Treating Mental Disorders Revenue (US$, Mn) & (2018-2023)
Table 33. Johnson and Johnson Key News & Latest Developments
Table 34. Pfizer Company Summary
Table 35. Pfizer Drugs for Treating Mental Disorders Product Offerings
Table 36. Pfizer Drugs for Treating Mental Disorders Revenue (US$, Mn) & (2018-2023)
Table 37. Pfizer Key News & Latest Developments
Table 38. Eli Lilly Company Summary
Table 39. Eli Lilly Drugs for Treating Mental Disorders Product Offerings
Table 40. Eli Lilly Drugs for Treating Mental Disorders Revenue (US$, Mn) & (2018-2023)
Table 41. Eli Lilly Key News & Latest Developments
Table 42. GlaxoSmithKline Company Summary
Table 43. GlaxoSmithKline Drugs for Treating Mental Disorders Product Offerings
Table 44. GlaxoSmithKline Drugs for Treating Mental Disorders Revenue (US$, Mn) & (2018-2023)
Table 45. GlaxoSmithKline Key News & Latest Developments
Table 46. AstraZeneca Company Summary
Table 47. AstraZeneca Drugs for Treating Mental Disorders Product Offerings
Table 48. AstraZeneca Drugs for Treating Mental Disorders Revenue (US$, Mn) & (2018-2023)
Table 49. AstraZeneca Key News & Latest Developments
Table 50. Bristol-Myers Squibb Company Summary
Table 51. Bristol-Myers Squibb Drugs for Treating Mental Disorders Product Offerings
Table 52. Bristol-Myers Squibb Drugs for Treating Mental Disorders Revenue (US$, Mn) & (2018-2023)
Table 53. Bristol-Myers Squibb Key News & Latest Developments
Table 54. Teva Pharmaceutical Company Summary
Table 55. Teva Pharmaceutical Drugs for Treating Mental Disorders Product Offerings
Table 56. Teva Pharmaceutical Drugs for Treating Mental Disorders Revenue (US$, Mn) & (2018-2023)
Table 57. Teva Pharmaceutical Key News & Latest Developments
Table 58. Dr. Reddy's Laboratories Company Summary
Table 59. Dr. Reddy's Laboratories Drugs for Treating Mental Disorders Product Offerings
Table 60. Dr. Reddy's Laboratories Drugs for Treating Mental Disorders Revenue (US$, Mn) & (2018-2023)
Table 61. Dr. Reddy's Laboratories Key News & Latest Developments
Table 62. Apotex Inc. Company Summary
Table 63. Apotex Inc. Drugs for Treating Mental Disorders Product Offerings
Table 64. Apotex Inc. Drugs for Treating Mental Disorders Revenue (US$, Mn) & (2018-2023)
Table 65. Apotex Inc. Key News & Latest Developments
Table 66. Mylan Pharmaceuticals Company Summary
Table 67. Mylan Pharmaceuticals Drugs for Treating Mental Disorders Product Offerings
Table 68. Mylan Pharmaceuticals Drugs for Treating Mental Disorders Revenue (US$, Mn) & (2018-2023)
Table 69. Mylan Pharmaceuticals Key News & Latest Developments
Table 70. Par Pharmaceutical Company Summary
Table 71. Par Pharmaceutical Drugs for Treating Mental Disorders Product Offerings
Table 72. Par Pharmaceutical Drugs for Treating Mental Disorders Revenue (US$, Mn) & (2018-2023)
Table 73. Par Pharmaceutical Key News & Latest Developments
Table 74. Aurobindo Pharma Company Summary
Table 75. Aurobindo Pharma Drugs for Treating Mental Disorders Product Offerings
Table 76. Aurobindo Pharma Drugs for Treating Mental Disorders Revenue (US$, Mn) & (2018-2023)
Table 77. Aurobindo Pharma Key News & Latest Developments
Table 78. Torrent Pharmaceuticals Company Summary
Table 79. Torrent Pharmaceuticals Drugs for Treating Mental Disorders Product Offerings
Table 80. Torrent Pharmaceuticals Drugs for Treating Mental Disorders Revenue (US$, Mn) & (2018-2023)
Table 81. Torrent Pharmaceuticals Key News & Latest Developments
Table 82. Jubilant Lifesciences Company Summary
Table 83. Jubilant Lifesciences Drugs for Treating Mental Disorders Product Offerings
Table 84. Jubilant Lifesciences Drugs for Treating Mental Disorders Revenue (US$, Mn) & (2018-2023)
Table 85. Jubilant Lifesciences Key News & Latest Developments
Table 86. Sun Pharmaceutical Company Summary
Table 87. Sun Pharmaceutical Drugs for Treating Mental Disorders Product Offerings
Table 88. Sun Pharmaceutical Drugs for Treating Mental Disorders Revenue (US$, Mn) & (2018-2023)
Table 89. Sun Pharmaceutical Key News & Latest Developments
Table 90. Sandoz (Novartis) Company Summary
Table 91. Sandoz (Novartis) Drugs for Treating Mental Disorders Product Offerings
Table 92. Sandoz (Novartis) Drugs for Treating Mental Disorders Revenue (US$, Mn) & (2018-2023)
Table 93. Sandoz (Novartis) Key News & Latest Developments
Table 94. Hansoh Pharmaceutical Company Summary
Table 95. Hansoh Pharmaceutical Drugs for Treating Mental Disorders Product Offerings
Table 96. Hansoh Pharmaceutical Drugs for Treating Mental Disorders Revenue (US$, Mn) & (2018-2023)
Table 97. Hansoh Pharmaceutical Key News & Latest Developments
Table 98. WATSON Pharmaceuticals Company Summary
Table 99. WATSON Pharmaceuticals Drugs for Treating Mental Disorders Product Offerings
Table 100. WATSON Pharmaceuticals Drugs for Treating Mental Disorders Revenue (US$, Mn) & (2018-2023)
Table 101. WATSON Pharmaceuticals Key News & Latest Developments
Table 102. Zhejiang Langhua Pharmaceuticals Company Summary
Table 103. Zhejiang Langhua Pharmaceuticals Drugs for Treating Mental Disorders Product Offerings
Table 104. Zhejiang Langhua Pharmaceuticals Drugs for Treating Mental Disorders Revenue (US$, Mn) & (2018-2023)
Table 105. Zhejiang Langhua Pharmaceuticals Key News & Latest Developments
Table 106. Forest Laboratories Company Summary
Table 107. Forest Laboratories Drugs for Treating Mental Disorders Product Offerings
Table 108. Forest Laboratories Drugs for Treating Mental Disorders Revenue (US$, Mn) & (2018-2023)
Table 109. Forest Laboratories Key News & Latest Developments
Table 110. H.Lundbeck A/S Company Summary
Table 111. H.Lundbeck A/S Drugs for Treating Mental Disorders Product Offerings
Table 112. H.Lundbeck A/S Drugs for Treating Mental Disorders Revenue (US$, Mn) & (2018-2023)
Table 113. H.Lundbeck A/S Key News & Latest Developments
Table 114. Amneal Pharmaceuticals Company Summary
Table 115. Amneal Pharmaceuticals Drugs for Treating Mental Disorders Product Offerings
Table 116. Amneal Pharmaceuticals Drugs for Treating Mental Disorders Revenue (US$, Mn) & (2018-2023)
Table 117. Amneal Pharmaceuticals Key News & Latest Developments
Table 118. Hetero Drugs Company Summary
Table 119. Hetero Drugs Drugs for Treating Mental Disorders Product Offerings
Table 120. Hetero Drugs Drugs for Treating Mental Disorders Revenue (US$, Mn) & (2018-2023)
Table 121. Hetero Drugs Key News & Latest Developments
Table 122. Macleods Pharmaceuticals Company Summary
Table 123. Macleods Pharmaceuticals Drugs for Treating Mental Disorders Product Offerings
Table 124. Macleods Pharmaceuticals Drugs for Treating Mental Disorders Revenue (US$, Mn) & (2018-2023)
Table 125. Macleods Pharmaceuticals Key News & Latest Developments
Table 126. Silarx Pharmacueticals Company Summary
Table 127. Silarx Pharmacueticals Drugs for Treating Mental Disorders Product Offerings
Table 128. Silarx Pharmacueticals Drugs for Treating Mental Disorders Revenue (US$, Mn) & (2018-2023)
Table 129. Silarx Pharmacueticals Key News & Latest Developments
Table 130. Hikma Pharmaceuticals Company Summary
Table 131. Hikma Pharmaceuticals Drugs for Treating Mental Disorders Product Offerings
Table 132. Hikma Pharmaceuticals Drugs for Treating Mental Disorders Revenue (US$, Mn) & (2018-2023)
Table 133. Hikma Pharmaceuticals Key News & Latest Developments
Table 134. Lupin Limited Company Summary
Table 135. Lupin Limited Drugs for Treating Mental Disorders Product Offerings
Table 136. Lupin Limited Drugs for Treating Mental Disorders Revenue (US$, Mn) & (2018-2023)
Table 137. Lupin Limited Key News & Latest Developments
Table 138. Prinston Pharmaceutical Company Summary
Table 139. Prinston Pharmaceutical Drugs for Treating Mental Disorders Product Offerings
Table 140. Prinston Pharmaceutical Drugs for Treating Mental Disorders Revenue (US$, Mn) & (2018-2023)
Table 141. Prinston Pharmaceutical Key News & Latest Developments
Table 142. STI Pharma Company Summary
Table 143. STI Pharma Drugs for Treating Mental Disorders Product Offerings
Table 144. STI Pharma Drugs for Treating Mental Disorders Revenue (US$, Mn) & (2018-2023)
Table 145. STI Pharma Key News & Latest Developments
List of Figures
Figure 1. Drugs for Treating Mental Disorders Segment by Type in 2022
Figure 2. Drugs for Treating Mental Disorders Segment by Application in 2022
Figure 3. Global Drugs for Treating Mental Disorders Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Drugs for Treating Mental Disorders Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Drugs for Treating Mental Disorders Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Drugs for Treating Mental Disorders Revenue in 2022
Figure 8. By Type - Global Drugs for Treating Mental Disorders Revenue Market Share, 2018-2030
Figure 9. By Application - Global Drugs for Treating Mental Disorders Revenue Market Share, 2018-2030
Figure 10. By Type - Global Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Drugs for Treating Mental Disorders Revenue Market Share, 2018-2030
Figure 12. By Application - Global Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Drugs for Treating Mental Disorders Revenue Market Share, 2018-2030
Figure 14. By Region - Global Drugs for Treating Mental Disorders Revenue Market Share, 2018-2030
Figure 15. By Country - North America Drugs for Treating Mental Disorders Revenue Market Share, 2018-2030
Figure 16. US Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Drugs for Treating Mental Disorders Revenue Market Share, 2018-2030
Figure 20. Germany Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2018-2030
Figure 21. France Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Drugs for Treating Mental Disorders Revenue Market Share, 2018-2030
Figure 28. China Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2018-2030
Figure 32. India Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Drugs for Treating Mental Disorders Revenue Market Share, 2018-2030
Figure 34. Brazil Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Drugs for Treating Mental Disorders Revenue Market Share, 2018-2030
Figure 37. Turkey Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Drugs for Treating Mental Disorders Revenue, (US$, Mn), 2018-2030
Figure 41. Johnson and Johnson Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Pfizer Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Eli Lilly Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. GlaxoSmithKline Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. AstraZeneca Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Bristol-Myers Squibb Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Teva Pharmaceutical Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Dr. Reddy's Laboratories Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Apotex Inc. Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Mylan Pharmaceuticals Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Par Pharmaceutical Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Aurobindo Pharma Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Torrent Pharmaceuticals Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Jubilant Lifesciences Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Sun Pharmaceutical Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Sandoz (Novartis) Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Hansoh Pharmaceutical Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. WATSON Pharmaceuticals Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Zhejiang Langhua Pharmaceuticals Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Forest Laboratories Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. H.Lundbeck A/S Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 62. Amneal Pharmaceuticals Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 63. Hetero Drugs Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 64. Macleods Pharmaceuticals Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 65. Silarx Pharmacueticals Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 66. Hikma Pharmaceuticals Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 67. Lupin Limited Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 68. Prinston Pharmaceutical Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 69. STI Pharma Drugs for Treating Mental Disorders Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
